Substituted spirocyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
US10759751B2 · kind B2 · utility
12Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2019 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | Mar 7, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to compounds that are agonists of the muscarinic M1 receptor or M1 and M4 receptors and which are useful in the treatment of muscarinic M1 or M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula wherein Q4, Q5, R5, p, V, Q1, Q2, X1, X2 and W are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.